Emmes acquires VaxTRIALS
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The delegation's visit covered a wide range of topics
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
Commenced operations in flood-affected Himachal Pradesh
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Subscribe To Our Newsletter & Stay Updated